172 related articles for article (PubMed ID: 28697973)
21. Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders.
Cataldo A; Rebeck GW; Ghetri B; Hulette C; Lippa C; Van Broeckhoven C; van Duijn C; Cras P; Bogdanovic N; Bird T; Peterhoff C; Nixon R
Ann Neurol; 2001 Nov; 50(5):661-5. PubMed ID: 11706973
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipids: critical players in Alzheimer's disease.
van Echten-Deckert G; Walter J
Prog Lipid Res; 2012 Oct; 51(4):378-93. PubMed ID: 22835784
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions.
Toh WH; Gleeson PA
Biochem J; 2016 Jul; 473(14):1977-93. PubMed ID: 27407168
[TBL] [Abstract][Full Text] [Related]
24. Depletion of ESCRT ameliorates APP-induced AD-like symptoms in Drosophila.
Zhuang L; Li C; Peng F; Xue E; Li W; Sun X; Chen P; Zhou Q; Xue L
J Cell Physiol; 2023 Jul; 238(7):1567-1579. PubMed ID: 37183375
[TBL] [Abstract][Full Text] [Related]
25. Low-Density Lipoprotein Receptor-Related Protein-1 (LRP1) C4408R Mutant Promotes Amyloid Precursor Protein (APP) α-Cleavage in Vitro.
Hou H; Habib A; Zi D; Tian K; Tian J; Giunta B; Sawmiller D; Tan J
Neuromolecular Med; 2017 Sep; 19(2-3):300-308. PubMed ID: 28612181
[TBL] [Abstract][Full Text] [Related]
26. Retromers in Alzheimer's disease.
Siegenthaler BM; Rajendran L
Neurodegener Dis; 2012; 10(1-4):116-21. PubMed ID: 22398391
[TBL] [Abstract][Full Text] [Related]
27. ELISA analysis of beta-secretase cleavage of the Swedish amyloid precursor protein in the secretory and endocytic pathways.
Steinhilb ML; Turner RS; Gaut JR
J Neurochem; 2002 Mar; 80(6):1019-28. PubMed ID: 11953452
[TBL] [Abstract][Full Text] [Related]
28. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
Gandy S; Petanceska S
Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
[TBL] [Abstract][Full Text] [Related]
30. The Role of SORL1 in Alzheimer's Disease.
Yin RH; Yu JT; Tan L
Mol Neurobiol; 2015; 51(3):909-18. PubMed ID: 24833601
[TBL] [Abstract][Full Text] [Related]
31. N-glycan and Alzheimer's disease.
Kizuka Y; Kitazume S; Taniguchi N
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
[TBL] [Abstract][Full Text] [Related]
32. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.
Xu W; Weissmiller AM; White JA; Fang F; Wang X; Wu Y; Pearn ML; Zhao X; Sawa M; Chen S; Gunawardena S; Ding J; Mobley WC; Wu C
J Clin Invest; 2016 May; 126(5):1815-33. PubMed ID: 27064279
[TBL] [Abstract][Full Text] [Related]
33. Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer's disease-like amyloid pathology.
Thomas RS; Lelos MJ; Good MA; Kidd EJ
Biochem Biophys Res Commun; 2011 Dec; 415(4):656-61. PubMed ID: 22079091
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
35. Dynein dysfunction disrupts intracellular vesicle trafficking bidirectionally and perturbs synaptic vesicle docking via endocytic disturbances a potential mechanism underlying age-dependent impairment of cognitive function.
Kimura N; Okabayashi S; Ono F
Am J Pathol; 2012 Feb; 180(2):550-61. PubMed ID: 22182700
[TBL] [Abstract][Full Text] [Related]
36. Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein.
Ben Halima S; Mishra S; Raja KMP; Willem M; Baici A; Simons K; Brüstle O; Koch P; Haass C; Caflisch A; Rajendran L
Cell Rep; 2016 Mar; 14(9):2127-2141. PubMed ID: 26923602
[TBL] [Abstract][Full Text] [Related]
37. Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer's Disease.
Alsaqati M; Thomas RS; Kidd EJ
J Gerontol A Biol Sci Med Sci; 2018 Mar; 73(3):289-298. PubMed ID: 28655199
[TBL] [Abstract][Full Text] [Related]
38. Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.
Zhang YW; Xu H
Curr Mol Med; 2007 Nov; 7(7):687-96. PubMed ID: 18045146
[TBL] [Abstract][Full Text] [Related]
39. Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model.
Liao F; Jiang H; Srivatsan S; Xiao Q; Lefton KB; Yamada K; Mahan TE; Lee JM; Shaw AS; Holtzman DM
Mol Neurodegener; 2015 Mar; 10():12. PubMed ID: 25887956
[TBL] [Abstract][Full Text] [Related]
40. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
